keywords

  • teadustegevus biotehnoloogias

Employees and salaries

ASPER BIOGENE OÜ

Number of employees and estimated average salaries
?

ASPER BIOGENE OÜ

Employee taxes and performance analysis
?
QuarterLabor taxes
paid
Number of employees
Turnover
Per Employee
Profit
per employee
2024 I........................
2023 IV........................
2023 III........................
2023 II........................
2023 I........................
2022 IV........................
2022 III........................
2022 II........................
2022 I........................
2021 IV........................
2021 III........................
2021 II........................
2021 I........................
2020 IV........................
2020 III........................
2020 II........................
2020 I........................
2019 IV........................
2019 III........................
2019 II........................
2019 I........................
2018 IV........................
2018 III........................
2018 II........................
2018 I........................
2017 IV........................
2017 III........................
2017 II........................

Deciders and beneficiaries

ASPER BIOGENE OÜ

Deciders
?

Former deciders


*Every member of the management board may represent the private limited company in concluding all transactions.

ASPER BIOGENE OÜ

Former deciders
?
Annetriin Treier
★★★★

......

Credit Score: Trustworthy

Reputation scores: 70

Date of birth: ......

Active relations 1

Eneli Oitmaa
★★★★

......

Credit Score: Trustworthy

Reputation scores: 470

Date of birth: ......

Active relations 1

Toomas Peterson
★★★★

......

Credit Score: Trustworthy

Reputation scores: 1090

Date of birth: ......

Active relations 2

ASPER BIOGENE OÜ

Owners
?

Former owners

NameCredit ScorePaymentBeginningTypeHolding
0.02
..................
100%

Former owners

NameCredit ScorePaymentBeginningEnd
0.01
..................

ASPER BIOGENE OÜ

Subsidiaries and associates
?

Former subsidiaries and associates

NameCredit ScorePaymentBeginningTypeHolding
0.01
..................
33%

Former subsidiaries and associates

NameCredit ScorePaymentBeginningEnd
0.01
..................
0.02
..................

Beneficiaries

Volumes and values ​​of beneficiaries' assets

Finances and assets

ASPER BIOGENE OÜ

Goodwill

ASPER BIOGENE OÜ

Paid taxes and estimated average salaries

ASPER BIOGENE OÜ

The number of days buyers have not paid
?

ASPER BIOGENE OÜ

Quarterly indicators
QuarterTurnoverTaxed turnoverLabor productivityLabor productivityEmployeesNational taxesLabor taxes
2024 I* ............* ..............................
2023 IV* ............* ..............................
2023 III* ............* ..............................
2023 II* ............* ..............................
2023 I* ............* ..............................
2022 IV* ............* ..............................
2022 III* ............* ..............................
2022 II* ............* ..............................
2022 I* ............* ..............................
2021 IV* ............* ..............................
2021 III* ............* ..............................
2021 II* ............* ..............................
2021 I* ............* ..............................
2020 IV* ............* ..............................
2020 III* ............* ..............................
2020 II* ............* ..............................
2020 I* ............* ..............................
2019 IV* ............* ..............................
2019 III* ............* ..............................
2019 II* ............* ..............................
2019 I* ............* ..............................
2018 IV* ............* ..............................
2018 III* ............* ..............................
2018 II* ............* ..............................
2018 I* ............* ..............................
2017 IV* ............* ..............................
2017 III* ............* ..............................
2017 II* ............* ..............................

ASPER BIOGENE OÜ

Sales revenue by business area

ASPER BIOGENE OÜ

Sales revenue by country

ASPER BIOGENE OÜ

Financial indicators and prognosis

ASPER BIOGENE OÜ

Financial raiting: "VERY GOOD" (2024 prognosis)
2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good

ASPER BIOGENE OÜ

Real estate as of 08.05.2024

Real estate MISSING

ASPER BIOGENE OÜ

Annual reports
Year Period Submitted Report PDF
2022 01.01.2022–31.12.2022 26.06.2023 ......
2021 01.01.2021–31.12.2021 30.06.2022 ......
2020 01.01.2020–31.12.2020 25.06.2021 ......
2019 01.01.2019–31.12.2019 02.07.2020 ......
2018 01.01.2018–31.12.2018 29.06.2019 ......
2017 01.01.2017–31.12.2017 30.06.2018 ......

Liabilities and debts

ASPER BIOGENE OÜ

Credit score history and prognosis
Recommended credit limit

... €

Recommended payment term

......

Business risk classes:

Trustworthy Neutral
Borderline Problematic Risky

ASPER BIOGENE OÜ

Reports and assets-liabilities overview 08.05.2024
?
Annual reports: ......
Annual reports: ......
Tax declarations:......

Assets to cover liabilities (short term)
Assets: ...... €1 EURO asset to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €

ASPER BIOGENE OÜ

Claims history
?
1 month
6 months
1 year
5 years
MAX
Debt claims as of ......
Tax debt ...... €
Debt claims ...... €

Total debt claims: ...... €

Latest events
...... ......

ASPER BIOGENE OÜ

Income (turnover) and expenditure (taxes paid)
?
QuarterTurnoverTaxed turnoverNational taxes paidLabor taxes paidNumber of employees
2024 I* ...... €...... €...... €...... €......
2023 IV* ...... €...... €...... €...... €......
2023 III* ...... €...... €...... €...... €......
2023 II* ...... €...... €...... €...... €......
2023 I* ...... €...... €...... €...... €......
2022 IV* ...... €...... €...... €...... €......
2022 III* ...... €...... €...... €...... €......
2022 II* ...... €...... €...... €...... €......
2022 I* ...... €...... €...... €...... €......
2021 IV* ...... €...... €...... €...... €......
2021 III* ...... €...... €...... €...... €......
2021 II* ...... €...... €...... €...... €......
2021 I* ...... €...... €...... €...... €......
2020 IV* ...... €...... €...... €...... €......
2020 III* ...... €...... €...... €...... €......
2020 II* ...... €...... €...... €...... €......
2020 I* ...... €...... €...... €...... €......
2019 IV* ...... €...... €...... €...... €......
2019 III* ...... €...... €...... €...... €......
2019 II* ...... €...... €...... €...... €......
2019 I* ...... €...... €...... €...... €......
2018 IV* ...... €...... €...... €...... €......
2018 III* ...... €...... €...... €...... €......
2018 II* ...... €...... €...... €...... €......
2018 I* ...... €...... €...... €...... €......
2017 IV* ...... €...... €...... €...... €......
2017 III* ...... €...... €...... €...... €......
2017 II* ...... €...... €...... €...... €......

ASPER BIOGENE OÜ

Court orders in the register as of 08.05.2024
?

Court order MISSING

ASPER BIOGENE OÜ

Decisions of the Consumer Disputes Committee as of 08.05.2024
?

Consumer disputes MISSING

ASPER BIOGENE OÜ

Court hearings as of 08.05.2024
?

Court hearings MISSING

ASPER BIOGENE OÜ

Rulings as of 08.05.2024
?

Court settlemets MISSING

ASPER BIOGENE OÜ

Notices and announcements as of 08.05.2024
?
Logo

Notice of issuing an activity licence for handling of infectious material

22.09.2017
Nakkusohtliku materjali käitlemise tegevusloa väljaandmise teade
Avaldamise algus: 22.09.2017
Avaldamise lõpp: tähtajatu
Terviseamet avaldab teadaande nakkushaiguste ennetamise ja tõrje seaduse (NETS) § 34 lõike 3 alusel.

Terviseamet teatab, et taotlejale Asper Biogene OÜ laborile (registrikood: 14265334) asukohaga Vaksali 17A, Tartu on 18.09.2017 antud nakkusohtliku materjali käitlemise tegevusluba nr 81.

Tegevusloaga anti luba käidelda 2. ohurühma kuuluvaid patogeene.

Loaga saab tutvuda tööpäevadel Terviseametis, Hiiu 42, Tallinn 11619.
Loa kehtivus on 5 aastat (NETS § 37).
Ärinimed
Asper Biogene OÜ laborile, kehtetud ärinimed: Mendel OÜ.
Terviseamet
Paldiski mnt 81, Tallinn, 10617
Telefon: 7943500
E-post: kesk@terviseamet.ee
Teadaande avaldaja kontaktandmed:
peadirektori asetäitja (järelevalve) Mihhail Muzõtšin
Telefon: 6943 703
E-post: mihhail.muzotsin@terviseamet.ee
Teadaande number 1195067

Marketing

Business network

ASPER BIOGENE OÜ

Business network
CREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired

Beneficiaries network

ASPER BIOGENE OÜ

Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired

Monitoring events

Filter

Dropdown

Year

Dropdown

Type

Neutral

Positive

Negative

No monitoring events were found

Failed to load monitoring events